Scarica l'app Stockscreener
1.16
2.65%
0.03
Pre-mercato:
1.18
0.02
+1.72%
Pasithea Therapeutics Corp Borsa (KTTA) Ultime notizie
Pasithea Therapeutics regains Nasdaq compliance - MSN
Pasithea Therapeutics regains Nasdaq compliance with minimum bid price rule - Investing.com
Pasithea Therapeutics Regains Nasdaq Compliance - TipRanks
Market Review: Is Pasithea Therapeutics Corp stock a contrarian buy2025 Top Gainers & Safe Capital Allocation Plans - moha.gov.vn
SCHNEIDERMAN DANIEL H Insider Trades - Nasdaq
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Pasithea Therapeutics Corp - GuruFocus
Pasithea Therapeutics (NASDAQ:KTTA) Upgraded at Zacks Research - Defense World
Pasithea Therapeutics Corp. (KTTA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Did KTTA Stock Soar A Whopping 48% Today? - MSN
What is HC Wainwright’s Forecast for KTTA FY2025 Earnings? - Defense World
HC Wainwright Begins Coverage on Pasithea Therapeutics (NASDAQ:KTTA) - Defense World
There is no way Pasithea Therapeutics Corp (KTTA) can keep these numbers up - setenews.com
Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria
HC Wainwright & Co. Initiates Coverage of Pasithea Therapeutics (KTTA) with Buy Recommendation - Nasdaq
Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright - Investing.com
HC Wainwright Initiates Coverage on Pasithea Therapeutics With Buy Rating, $3 Price Target - marketscreener.com
MSN Money - MSN
Is Pasithea Therapeutics Corp. stock attractive for hedge funds2025 Top Decliners & Technical Confirmation Trade Alerts - Newser
Small Cap Stocks To ConsiderNovember 30th - MarketBeat
Will Pasithea Therapeutics Corp. Equity Warrant stock benefit from commodity prices2025 Dividend Review & Weekly Top Performers Watchlists - Newser
Insiders Buying Pasithea Therapeutics Might Wish They Invested More, Stock Gains 10% - Yahoo Finance
Pasithea Therapeutics Reaches US$104m Market Cap Benefiting Insider Stock Buying - simplywall.st
Lawrence Steinman Bought 201% More Shares In Pasithea Therapeutics - Yahoo Finance
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Top Biotech Stocks To Watch TodayNovember 29th - MarketBeat
Small Cap Stocks To Follow NowNovember 29th - MarketBeat
Best Small Cap Stocks To Keep An Eye OnNovember 28th - MarketBeat
Pasithea Therapeutics Completes $60M Public Offering - TipRanks
Best Penny Stocks To Watch TodayNovember 29th - MarketBeat
Pasithea Therapeutics announces closing of $60 million public offering of common stock - marketscreener.com
Pasithea Therapeutics (Nasdaq: KTTA) raises $60M, extends cash runway into 2028 - Stock Titan
Promising Penny Stocks To Consider – November 30th - Defense World
Small Cap Stocks To Consider – November 30th - Defense World
Published on: 2025-12-02 03:15:38 - Newser
Biotech Stocks To Watch Today – November 30th - Defense World
Pasithea Therapeutics (KTTA) Stock Analysis Report | Financials & Insights - Benzinga
Insider Buying Spree at Pasithea Therapeutics: Top Executives Invest Big! - TipRanks
Biotech Stocks To Watch TodayNovember 30th - MarketBeat
Pasithea Therapeutics Stock (KTTA) Opinions on PAS-004 Drug Updates - Quiver Quantitative
Pasithea therapeutics (KTTA) director Steinman buys $99,999 in stock By Investing.com - Investing.com Canada
Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares By Investing.com - Investing.com Canada
Marques buys Pasithea Therapeutics (KTTA) shares worth $24999 By Investing.com - Investing.com Canada
Pasithea therapeutics (KTTA) director Steinman buys $99,999 in stock - Investing.com India
Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares - Investing.com
Marques buys Pasithea Therapeutics (KTTA) shares worth $24999 - Investing.com
Pasithea Therapeutics Executives and Directors Make Significant Stock Purchases - TradingView — Track All Markets
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):